 JL, Lazar RM, Levin B, Sacco RL, Furie KL, et al.
A comparison of warfarin and aspirin for the prevention of recurrent
ischemic stroke. N Engl J Med 2001;345:1444-51.
129. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Medium
intensity oral anticoagulants versus aspirin after cerebral ischaemia
of arterial origin (ESPRIT): a randomised controlled trial. Lancet
Neurol 2007;6:115-24.
130. De Schryver EL, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ.
Vitamin K antagonists versus antiplatelet therapy after transient
ischaemic attack or minor ischaemic stroke of presumed arterial
origin. Cochrane Database Syst Rev 2012:Cd001342.
131. A randomised, blinded, trial of clopidogrel versus aspirin in patients
at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
Lancet 1996;348:1329-39.
132. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus
dipyridamole versus aspirin alone after cerebral ischaemia of arterial
origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665-73.
133. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al.
Aspirin and extended-release dipyridamole versus clopidogrel for
recurrent stroke. N Engl J Med 2008;359:1238-51.
134. Zhang JJ, Liu X. Aspirin plus dipyridamole has the highest surface
under the cumulative ranking curves (SUCRA) values in terms of
mortality, intracranial hemorrhage, and adverse event rate among 7
